Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vaxcyte, Inc. Director's Dealing 2024

Nov 19, 2024

31100_dirs_2024-11-19_cc58f64f-e3a6-48e2-9cb2-b3b8ca3d7633.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2024-11-18

Reporting Person: PICKERING GRANT (Director, CHIEF EXECUTIVE OFFICER)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-11-18 Common Stock G 710 Disposed 465301 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 137398 Indirect
Common Stock 137398 Indirect

Footnotes

F1: Represents a bona fide gift of the Issuer's Common Stock to a non-profit educational institution made via a donor advised fund.

F2: Shares are held directly by a trust for the benefit of the Reporting Person's daughter.

F3: Shares are held directly by a trust for the benefit of the Reporting Person's son.